+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-invasive Prenatal Testing (NIPT) Market Size, Share & Industry Trends Analysis Report By Product, By Application, By End User (Diagnostic Laboratories, Hospitals & Clinics), By Technology, By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • October 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5935312
The Global Non-invasive Prenatal Testing (NIPT) Market size is expected to reach $17.7 billion by 2030, rising at a market growth of 18.1% CAGR during the forecast period.

Continuous research and development efforts have led to enhancements in the sensitivity and specificity of NIPT. This means NIPT can detect genetic abnormalities with even greater accuracy, reducing the risk of false negatives and positives. Therefore, the Next Generation Sequencing (NGS) segment captured $ 2,897.6 million revenue in the market in 2022. The improved performance is a significant driver for the adoption of NIPT. Advances in genetics and genomics have expanded the range of conditions NIPT can detect. Initially designed to identify common chromosomal abnormalities, NIPT can now detect a broader spectrum of genetic conditions, including rare genetic disorders and microdeletions. This expanded capability makes NIPT more comprehensive and attractive to expectant parents. Some of the factors impacting the market are high accuracy in detecting fetal chromosomal abnormalities, increasing awareness of their benefits, and high cost of these procedures.



The high accuracy and low false-positive rate of NIPT results instill trust and confidence in expectant parents and healthcare providers. When individuals receive NIPT results, they can be more confident in the information provided. This trust is a vital factor that positively impacts the market, as it encourages more individuals to choose NIPT over traditional screening methods. Expectant parents seek the most accurate and reliable information about their baby's health. Additionally, greater awareness and demand for NIPT naturally expands the market size. As more expectant parents seek out this non-invasive testing option, the customer base for NIPT providers grows. This leads to a larger market share and, potentially, increased revenue for NIPT companies. The demand for NIPT drives competition among providers, fostering innovation. Owing to these factors, the market will grow rapidly in the upcoming years.

However, the high cost of NIPT can limit its adoption among a significant portion of the population, particularly lower-income individuals and families. As a result, the market's potential for growth is constrained because a substantial market segment is unable to afford the testing. The cost disparity between NIPT and traditional screening methods can exacerbate healthcare inequities. Individuals without the financial means or adequate insurance coverage may be deprived of the benefits of advanced prenatal testing. This results in unequal access to superior healthcare, raising ethical and equity concerns. Thus, these factors can impede the future growth of the market.

Moreover, the pandemic led to a disruption in routine prenatal care visits. Many pregnant individuals delayed or canceled appointments to avoid the risk of contracting the virus. This impacted the timing and uptake of NIPT, as the recommended gestational age for testing is crucial for accurate results. Healthcare facilities were forced to reallocate resources to manage COVID-19 patients, which in some cases affected the availability and scheduling of prenatal care services, including NIPT. Many pregnant individuals turned to telehealth for consultations, reducing their in-person visits to healthcare facilities. NIPT providers began to explore telehealth options for consultations and result delivery to adapt to changing patient preferences. Therefore, the COVID-19 pandemic disrupted various aspects of the market.

Product Outlook

Based on product, the market is bifurcated into consumables & reagents and instruments. In 2022, the instruments segment garnered a significant revenue share in the market. One of the primary drivers of the instruments segment's growth is the continuous evolution and improvement in NIPT technology. Advances in sequencing technologies, automation, and data analysis have led to more accurate and efficient NIPT instruments. As these technologies mature and become more accessible, the demand for upgraded instruments increases. Therefore, there will be increased demand in the instruments segment.

Application Outlook

On the basis of application, the market is divided into trisomy, microdeletion syndrome, and others. The trisomy segment garnered the highest revenue share in the market in 2022. NIPT allows for the early detection of Trisomy conditions, typically as early as the 10th week of pregnancy. This early detection provides ample time for expectant parents to consider their options, make informed decisions, and plan for the future. As a result, there is no need for invasive procedures such as amniocentesis or chorionic villus sampling (CVS), which carry a small risk of complications and miscarriage.



End-user Outlook

Based on end user, the market is divided into diagnostic laboratories and hospitals & clinics. In 2022, the hospitals and clinics segment witnessed a substantial revenue share in the market. Hospitals are pivotal in providing comprehensive prenatal care to expectant mothers. This care encompasses various aspects, including regular check-ups, ultrasounds, and prenatal testing. The demand for NIPT is rising as it offers a non-invasive and accurate method for screening genetic abnormalities and chromosomal disorders, and hospitals are well-equipped to offer these services.

Technology Outlook

On the basis of technology, the market is divided into next-generation sequencing (NGS), microarray, polymerase chain reaction (PCR), and rolling circular amplification. In 2022, the rolling circular amplification segment witnessed a substantial revenue share in the market. Rolling circular amplification (RCA) technology offers improved sensitivity and specificity in detecting fetal genetic abnormalities. This is especially important for NIPT, as accurate results are crucial for making informed decisions about pregnancy management. RCA enables the detection of rare genetic variants, which traditional NIPT methods may miss. This expanded capability increases the diagnostic power of NIPT, making it a preferred choice for expectant parents seeking comprehensive genetic information.

Regional Outlook

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America has been at the forefront of adopting and advancing genetic sequencing technologies. The region has access to state-of-the-art sequencing platforms, which have improved the accuracy and precision of NIPT. Integrating artificial intelligence (AI) and advanced bioinformatics in data analysis has enhanced the sensitivity and specificity of NIPT, making it more reliable and attractive for both healthcare providers and expectant parents. Owing to these factors, the demand will rise in the North America segment.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Illumina, Inc., Natera Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Thermo Fisher Scientific, Inc., GE HealthCare Technologies, Inc., Agilent Technologies, Inc., and Pacific Biosciences of California, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Product
  • Consumables & Reagents
  • Instruments
By Application
  • Trisomy
  • Microdeletion Syndrome
  • Others
By End User
  • Diagnostic Laboratories
  • Hospitals & Clinics
By Technology
  • Next Generation Sequencing (NGS)
  • Microarray
  • Polymerase Chain Reaction (PCR)
  • Rolling Circular Amplification
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America- Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe- Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific- LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Illumina, Inc.
  • Natera Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific SE
  • Thermo Fisher Scientific, Inc.
  • GE HealthCare Technologies, Inc.
  • Agilent Technologies, Inc.
  • Pacific Biosciences of California, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Non-invasive Prenatal Testing (NIPT) Market, by Product
1.4.2 Global Non-invasive Prenatal Testing (NIPT) Market, by Application
1.4.3 Global Non-invasive Prenatal Testing (NIPT) Market, by End User
1.4.4 Global Non-invasive Prenatal Testing (NIPT) Market, by Technology
1.4.5 Global Non-invasive Prenatal Testing (NIPT) Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Global Non-invasive Prenatal Testing (NIPT) Market by Product
4.1 Global Consumables & Reagents Market by Region
4.2 Global Instruments Market by Region
Chapter 5. Global Non-invasive Prenatal Testing (NIPT) Market by Application
5.1 Global Trisomy Market by Region
5.2 Global Microdeletion Syndrome Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Non-invasive Prenatal Testing (NIPT) Market by End User
6.1 Global Diagnostic Laboratories Market by Region
6.2 Global Hospitals & Clinics Market by Region
Chapter 7. Global Non-invasive Prenatal Testing (NIPT) Market by Technology
7.1 Global Next Generation Sequencing (NGS) Market by Region
7.2 Global Microarray Market by Region
7.3 Global Polymerase Chain Reaction (PCR) Market by Region
7.4 Global Rolling Circular Amplification Market by Region
Chapter 8. Global Non-invasive Prenatal Testing (NIPT) Market by Region
8.1 North America Non-invasive Prenatal Testing (NIPT) Market
8.1.1 North America Non-invasive Prenatal Testing (NIPT) Market by Product
8.1.1.1 North America Consumables & Reagents Market by Region
8.1.1.2 North America Instruments Market by Region
8.1.2 North America Non-invasive Prenatal Testing (NIPT) Market by Application
8.1.2.1 North America Trisomy Market by Country
8.1.2.2 North America Microdeletion Syndrome Market by Country
8.1.2.3 North America Others Market by Country
8.1.3 North America Non-invasive Prenatal Testing (NIPT) Market by End User
8.1.3.1 North America Diagnostic Laboratories Market by Country
8.1.3.2 North America Hospitals & Clinics Market by Country
8.1.4 North America Non-invasive Prenatal Testing (NIPT) Market by Technology
8.1.4.1 North America Next Generation Sequencing (NGS) Market by Country
8.1.4.2 North America Microarray Market by Country
8.1.4.3 North America Polymerase Chain Reaction (PCR) Market by Country
8.1.4.4 North America Rolling Circular Amplification Market by Country
8.1.5 North America Non-invasive Prenatal Testing (NIPT) Market by Country
8.1.5.1 US Non-invasive Prenatal Testing (NIPT) Market
8.1.5.1.1 US Non-invasive Prenatal Testing (NIPT) Market by Product
8.1.5.1.2 US Non-invasive Prenatal Testing (NIPT) Market by Application
8.1.5.1.3 US Non-invasive Prenatal Testing (NIPT) Market by End User
8.1.5.1.4 US Non-invasive Prenatal Testing (NIPT) Market by Technology
8.1.5.2 Canada Non-invasive Prenatal Testing (NIPT) Market
8.1.5.2.1 Canada Non-invasive Prenatal Testing (NIPT) Market by Product
8.1.5.2.2 Canada Non-invasive Prenatal Testing (NIPT) Market by Application
8.1.5.2.3 Canada Non-invasive Prenatal Testing (NIPT) Market by End User
8.1.5.2.4 Canada Non-invasive Prenatal Testing (NIPT) Market by Technology
8.1.5.3 Mexico Non-invasive Prenatal Testing (NIPT) Market
8.1.5.3.1 Mexico Non-invasive Prenatal Testing (NIPT) Market by Product
8.1.5.3.2 Mexico Non-invasive Prenatal Testing (NIPT) Market by Application
8.1.5.3.3 Mexico Non-invasive Prenatal Testing (NIPT) Market by End User
8.1.5.3.4 Mexico Non-invasive Prenatal Testing (NIPT) Market by Technology
8.1.5.4 Rest of North America Non-invasive Prenatal Testing (NIPT) Market
8.1.5.4.1 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Product
8.1.5.4.2 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Application
8.1.5.4.3 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by End User
8.1.5.4.4 Rest of North America Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2 Europe Non-invasive Prenatal Testing (NIPT) Market
8.2.1 Europe Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.1.1 Europe Consumables & Reagents Market by Country
8.2.1.2 Europe Instruments Market by Country
8.2.2 Europe Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.2.1 Europe Trisomy Market by Country
8.2.2.2 Europe Microdeletion Syndrome Market by Country
8.2.2.3 Europe Others Market by Country
8.2.3 Europe Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.3.1 Europe Diagnostic Laboratories Market by Country
8.2.3.2 Europe Hospitals & Clinics Market by Country
8.2.4 Europe Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2.4.1 Europe Next Generation Sequencing (NGS) Market by Country
8.2.4.2 Europe Microarray Market by Country
8.2.4.3 Europe Polymerase Chain Reaction (PCR) Market by Country
8.2.4.4 Europe Rolling Circular Amplification Market by Country
8.2.5 Europe Non-invasive Prenatal Testing (NIPT) Market by Country
8.2.5.1 Germany Non-invasive Prenatal Testing (NIPT) Market
8.2.5.1.1 Germany Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.5.1.2 Germany Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.5.1.3 Germany Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.5.1.4 Germany Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2.5.2 UK Non-invasive Prenatal Testing (NIPT) Market
8.2.5.2.1 UK Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.5.2.2 UK Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.5.2.3 UK Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.5.2.4 UK Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2.5.3 France Non-invasive Prenatal Testing (NIPT) Market
8.2.5.3.1 France Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.5.3.2 France Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.5.3.3 France Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.5.3.4 France Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2.5.4 Russia Non-invasive Prenatal Testing (NIPT) Market
8.2.5.4.1 Russia Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.5.4.2 Russia Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.5.4.3 Russia Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.5.4.4 Russia Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2.5.5 Spain Non-invasive Prenatal Testing (NIPT) Market
8.2.5.5.1 Spain Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.5.5.2 Spain Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.5.5.3 Spain Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.5.5.4 Spain Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2.5.6 Italy Non-invasive Prenatal Testing (NIPT) Market
8.2.5.6.1 Italy Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.5.6.2 Italy Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.5.6.3 Italy Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.5.6.4 Italy Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2.5.7 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market
8.2.5.7.1 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.5.7.2 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.5.7.3 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.5.7.4 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market
8.3.1 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.1.1 Asia Pacific Consumables & Reagents Market by Country
8.3.1.2 Asia Pacific Instruments Market by Country
8.3.2 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.2.1 Asia Pacific Trisomy Market by Country
8.3.2.2 Asia Pacific Microdeletion Syndrome Market by Country
8.3.2.3 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.3.1 Asia Pacific Diagnostic Laboratories Market by Country
8.3.3.2 Asia Pacific Hospitals & Clinics Market by Country
8.3.4 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3.4.1 Asia Pacific Next Generation Sequencing (NGS) Market by Country
8.3.4.2 Asia Pacific Microarray Market by Country
8.3.4.3 Asia Pacific Polymerase Chain Reaction (PCR) Market by Country
8.3.4.4 Asia Pacific Rolling Circular Amplification Market by Country
8.3.5 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Country
8.3.5.1 China Non-invasive Prenatal Testing (NIPT) Market
8.3.5.1.1 China Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.5.1.2 China Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.5.1.3 China Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.5.1.4 China Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3.5.2 Japan Non-invasive Prenatal Testing (NIPT) Market
8.3.5.2.1 Japan Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.5.2.2 Japan Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.5.2.3 Japan Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.5.2.4 Japan Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3.5.3 India Non-invasive Prenatal Testing (NIPT) Market
8.3.5.3.1 India Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.5.3.2 India Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.5.3.3 India Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.5.3.4 India Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3.5.4 South Korea Non-invasive Prenatal Testing (NIPT) Market
8.3.5.4.1 South Korea Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.5.4.2 South Korea Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.5.4.3 South Korea Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.5.4.4 South Korea Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3.5.5 Singapore Non-invasive Prenatal Testing (NIPT) Market
8.3.5.5.1 Singapore Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.5.5.2 Singapore Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.5.5.3 Singapore Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.5.5.4 Singapore Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3.5.6 Malaysia Non-invasive Prenatal Testing (NIPT) Market
8.3.5.6.1 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.5.6.2 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.5.6.3 Malaysia Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.5.6.4 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3.5.7 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market
8.3.5.7.1 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.5.7.2 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.5.7.3 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.5.7.4 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4 LAMEA Non-invasive Prenatal Testing (NIPT) Market
8.4.1 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.1.1 LAMEA Consumables & Reagents Market by Country
8.4.1.2 LAMEA Instruments Market by Country
8.4.2 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.2.1 LAMEA Trisomy Market by Country
8.4.2.2 LAMEA Microdeletion Syndrome Market by Country
8.4.2.3 LAMEA Others Market by Country
8.4.3 LAMEA Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.3.1 LAMEA Diagnostic Laboratories Market by Country
8.4.3.2 LAMEA Hospitals & Clinics Market by Country
8.4.4 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4.4.1 LAMEA Next Generation Sequencing (NGS) Market by Country
8.4.4.2 LAMEA Microarray Market by Country
8.4.4.3 LAMEA Polymerase Chain Reaction (PCR) Market by Country
8.4.4.4 LAMEA Rolling Circular Amplification Market by Country
8.4.5 LAMEA Non-invasive Prenatal Testing (NIPT) Market by Country
8.4.5.1 Brazil Non-invasive Prenatal Testing (NIPT) Market
8.4.5.1.1 Brazil Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.5.1.2 Brazil Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.5.1.3 Brazil Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.5.1.4 Brazil Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4.5.2 Argentina Non-invasive Prenatal Testing (NIPT) Market
8.4.5.2.1 Argentina Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.5.2.2 Argentina Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.5.2.3 Argentina Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.5.2.4 Argentina Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4.5.3 UAE Non-invasive Prenatal Testing (NIPT) Market
8.4.5.3.1 UAE Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.5.3.2 UAE Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.5.3.3 UAE Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.5.3.4 UAE Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4.5.4 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market
8.4.5.4.1 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.5.4.2 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.5.4.3 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.5.4.4 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4.5.5 South Africa Non-invasive Prenatal Testing (NIPT) Market
8.4.5.5.1 South Africa Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.5.5.2 South Africa Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.5.5.3 South Africa Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.5.5.4 South Africa Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4.5.6 Nigeria Non-invasive Prenatal Testing (NIPT) Market
8.4.5.6.1 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.5.6.2 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.5.6.3 Nigeria Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.5.6.4 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4.5.7 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market
8.4.5.7.1 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.5.7.2 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.5.7.3 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.5.7.4 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Technology
Chapter 9. Company Profiles
9.1 Illumina, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Natera Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 PerkinElmer, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 Laboratory Corporation of America Holdings
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental Analysis
9.5.4 SWOT Analysis
9.6 Eurofins Scientific SE
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Product Launches and Product Expansions:
9.6.5 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 WOT Analysis
9.8 GE HealthCare Technologies, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Pacific Biosciences of California, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
Chapter 10. Winning imperatives of Non-invasive Prenatal Testing (NIPT) Market

Companies Mentioned

  • Illumina, Inc.
  • Natera Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific SE
  • Thermo Fisher Scientific, Inc.
  • GE HealthCare Technologies, Inc.
  • Agilent Technologies, Inc.
  • Pacific Biosciences of California, Inc.

Methodology

Loading
LOADING...